Lipoprotein (a) and cardiovascular risk

International Journal of Cardiology

Volumn 74, Issue 2-3, 2000, Pages 169-170

  Schachter, Michael ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR RESPONSE; DISEASE ASSOCIATION; EDITORIAL; HIGH RISK POPULATION; HUMAN; LIPOPROTEIN METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0034738395     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00305-3     Document Type: Editorial

References (6)

1. I.J. Kullo, G.T. Gau, and A.J. Tajik Novel risk factors for atherosclerosis Mayo Clin Proc 75 2000 369 380
2. Pedreño J, Fernández R, Beilester A, Jornet A, Usón M, Cenela J, Petit M. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease. Int J Cardiol 2000.
3. L.B. Nielsen Atherogenicity of lipoprotein (a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and influx Atherosclerosis 143 1999 229 243
4. G. Lippi, and G. Guidi Biochemical risk factors and patients outcome: the case of lipoprotein (a) Clin Chim Acta 280 1999 59 71
5. W. Herrmann, S. Quast, A. Elgass, K. Wolter, S.T. Kiessig, E. Molinari, and W. Riegel An increased serum level of free apo(a) in renal patients is more striking than that of Ip(a) and is influenced by homocysteine Nephron 85 2000 41 49
6. Maher VMG, Brown G, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effects of lowering LDL cholesterol on the cardiovascular risk of lipoprotein (a). JAMA 1995;274:17714.